These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 18489854)
1. Role of secretory phospholipases in atherogenesis. Jönsson-Rylander AC; Lundin S; Rosengren B; Pettersson C; Hurt-Camejo E Curr Atheroscler Rep; 2008 Jun; 10(3):252-9. PubMed ID: 18489854 [TBL] [Abstract][Full Text] [Related]
2. Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes. Rosenson RS; Gelb MH Curr Cardiol Rep; 2009 Nov; 11(6):445-51. PubMed ID: 19863869 [TBL] [Abstract][Full Text] [Related]
3. Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis. Rosengren B; Jönsson-Rylander AC; Peilot H; Camejo G; Hurt-Camejo E Biochim Biophys Acta; 2006 Nov; 1761(11):1301-8. PubMed ID: 17070102 [TBL] [Abstract][Full Text] [Related]
4. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Jaross W; Eckey R; Menschikowski M Eur J Clin Invest; 2002 Jun; 32(6):383-93. PubMed ID: 12059982 [TBL] [Abstract][Full Text] [Related]
5. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet. Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231 [TBL] [Abstract][Full Text] [Related]
6. Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics. Yamamoto K; Isogai Y; Sato H; Taketomi Y; Murakami M Anal Bioanal Chem; 2011 Jun; 400(7):1829-42. PubMed ID: 21445663 [TBL] [Abstract][Full Text] [Related]
7. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Boyanovsky B; Zack M; Forrest K; Webb NR Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803 [TBL] [Abstract][Full Text] [Related]
8. Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Gesquiere L; Cho W; Subbaiah PV Biochemistry; 2002 Apr; 41(15):4911-20. PubMed ID: 11939786 [TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2. Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A Biochim Biophys Acta; 2007 Jan; 1771(1):5-19. PubMed ID: 17197234 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein modification by secretory phospholipase A(2) enzymes contributes to the initiation and progression of atherosclerosis. Oörni K; Kovanen PT Curr Opin Lipidol; 2009 Oct; 20(5):421-7. PubMed ID: 19593123 [TBL] [Abstract][Full Text] [Related]
11. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Ishimoto Y; Yamada K; Yamamoto S; Ono T; Notoya M; Hanasaki K Biochim Biophys Acta; 2003 Oct; 1642(3):129-38. PubMed ID: 14572896 [TBL] [Abstract][Full Text] [Related]
12. Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma. Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Uusitalo H Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):739-46. PubMed ID: 18196260 [TBL] [Abstract][Full Text] [Related]
13. The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis? Divchev D; Schieffer B Vasc Health Risk Manag; 2008; 4(3):597-604. PubMed ID: 18827909 [TBL] [Abstract][Full Text] [Related]
14. Opposite effects of native and oxidized lipoproteins on the activity of secretory phospholipase A(2) group IIA. Korotaeva AA; Samoilova EV; Pirkova AA; Ameliushkina VA; Prokazova NV; Tkachuk VA; Chazov EI Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):37-41. PubMed ID: 19647092 [TBL] [Abstract][Full Text] [Related]
15. Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins. Kamitani S; Yamada K; Yamamoto S; Ishimoto Y; Ono T; Saiga A; Hanasaki K Cell Mol Biol Lett; 2012 Sep; 17(3):459-78. PubMed ID: 22706677 [TBL] [Abstract][Full Text] [Related]
16. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice. Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of multiple secretory phospholipase A(2) isoforms in the rat CNS: enriched expression of sPLA(2)-IIA in brainstem and spinal cord. Ma MT; Nevalainen TJ; Yeo JF; Ong WY J Chem Neuroanat; 2010 Jul; 39(4):242-7. PubMed ID: 20153419 [TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. Peilot H; Rosengren B; Bondjers G; Hurt-Camejo E J Biol Chem; 2000 Jul; 275(30):22895-904. PubMed ID: 10811652 [TBL] [Abstract][Full Text] [Related]
19. Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans. Lähdesmäki K; Öörni K; Alanne-Kinnunen M; Jauhiainen M; Hurt-Camejo E; Kovanen PT Biochim Biophys Acta; 2012 Feb; 1821(2):257-67. PubMed ID: 22041135 [TBL] [Abstract][Full Text] [Related]
20. New phospholipase A(2) isozymes with a potential role in atherosclerosis. Murakami M; Kudo I Curr Opin Lipidol; 2003 Oct; 14(5):431-6. PubMed ID: 14501581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]